Reportable Diseases, Emergency Illnesses and Health Conditions, and Reportable Laboratory Findings Changes for 2013
Total Page:16
File Type:pdf, Size:1020Kb
Volume 33, No. 1 January 2013 Reportable Diseases, Emergency Illnesses In this issue... and Health Conditions, and Reportable Reportable Diseases, Emergency Illnesses and Health 1 Conditions, and Reportable Laboratory Findings - Laboratory Findings Changes for 2013 Changes for 2013 List of Reportable Diseases, Emergency Illnesses and 2 Health Conditions - 2013 As required by Connecticut General Statutes Section List of Reportable Laboratory Findings - 2013 3 19a-2a and Section 19a-36-A2 of the Public Health Code, Revisions to the Laboratory Significant Findings 4 the lists of Reportable Diseases, Emergency Illnesses and Report Form (OL-15C) Health Conditions, and Reportable Laboratory Findings Persons Required to Report Reportable Diseases, 4 are revised annually by the Department of Public Health Emergency Illnesses and Health Conditions, and (DPH). An advisory committee, consisting of public Reportable Laboratory Findings health officials, clinicians, and laboratorians, contribute to the process. There are 1 addition, 3 removals, and 1 bovine spongiform encephalopathy that results in vCJD in modification to the healthcare provider list, and 1 people. Free testing of patients for CJD is available at the addition, 1 removal, and 1 modification to the laboratory federally funded National Prion Disease Pathology list for 2013. Surveillance Center, Case Western Reserve University. Changes to the List of Reportable Diseases, Clostridium difficile, community-onset Emergency Illnesses and Health Conditions Reporting of Clostridium difficile, community-onset, Hemolytic uremic syndrome by providers has been removed. Over the past 6 years the Residual serum from hemolytic uremic syndrome incidence of community-onset C. difficile infection (CO (HUS) patients is to be sent to the Katherine A. Kelley CDI) has ranged from 3.5 to 5 cases per 100,000 State Public Health Laboratory (DPH Laboratory) on population using this passive surveillance system. The request from the DPH and if adequate serum is available more robust Emerging Infections Program ongoing active for additional Shiga toxin-producing Escherichia coli surveillance for CO CDI, will continue among New (STEC) antibody testing. STEC infections are the main Haven County residents. C. difficile reporting will also be cause of post-diarrheal HUS in the United States. The instituted by hospitals as required by the Centers for Centers for Disease Control and Prevention (CDC) does Medicare and Medicaid Services (CMS) to monitor serologic testing for STEC antibodies on specimens hospital-onset CDI. These 2 systems will be used to submitted from HUS patients without culture confirmed monitor CDI trends going forward. STEC infections as part of routine surveillance to monitor STEC-associated HUS. A footnote is being added to the Healthcare Associated Infections PD-23 form. The list is modified and expanded to follow the CMS annual payment update pay-for-reporting or pay-for- Reye Syndrome performance requirements for 2013. Therefore, reporting Reporting of Reye syndrome has been removed. in Connecticut, which uses the CDC’s National Although the syndrome was reportable for over two Healthcare Safety Network (NHSN) surveillance decades, the DPH has not received a single report of this definitions, protocols, and software, is expanded to syndrome in 25 years. At this time, Reye syndrome is not include Methicillin-resistant Staphylococcus aureus (MRSA) and C. difficile LabID events from acute care a condition that requires public health monitoring. hospitals, Central Line-Associated Bloodstream Creutzfeldt-Jakob disease Infections (CLABSIs) and Catheter-Associated Urinary Reporting of Creutzfeldt-Jakob disease (CJD) has Tract Infections (CAUTIs) from long term acute care been removed. Confirmation of CJD requires laboratory hospitals (LTACHs) and inpatient rehabilitation facilities confirmation. Since the outbreak of the variant CJD in the (IRFs), and NHSN dialysis events from outpatient United Kingdom, there have been no human cases of hemodialysis centers. vCJD acquired in the United States or the variant of (Continued on page 4) Connecticut Epidemiologist 1 REPORTABLE DISEASES, EMERGENCY ILLNESSES and HEALTH CONDITIONS - 2013 The Commissioner of the Department of Public Health (DPH) is required to declare an annual list of Reportable Diseases, Emergency Illnesses and Health Conditions. The Reportable Disease Confidential Case Report form (PD-23) or other disease specific form should be used to report the disease, illness, or condition. Reports (mailed, faxed, or telephoned into the DPH) should include the full name and address of the person reporting, attending physician, disease, illness or condition, and full name, address, date of birth, race/ethnicity, sex and occupation of the person affected. Forms can be found on the DPH website. See page 4 for a list of persons required to report Reportable Diseases, Emergency Illnesses and Health Conditions. Mailed reports must be sent in envelopes marked “CONFIDENTIAL.” Changes for 2013 are noted in bold and with an asterisk (*). Category 1 Diseases: Report immediately by telephone on the day of recognition or strong suspicion of disease for those diseases marked with a telephone (). Also mail a report within 12 hours. Category 2 Diseases: Diseases not marked with a telephone are Category 2 diseases. Report by mail within 12 hours of recognition or strong suspicion of disease. Acquired Immunodeficiency Syndrome (1,2) >5mm induration by Mantoux technique) SARS-CoV Anthrax ▪ persons of any age Septicemia or meningitis with growth of Arboviral disease (California group, Dengue, ▪ pregnant women gram positive rods within 32 hours of EEE, SLE, WNV) HPV: biopsy proven CIN 2, CIN 3 or AIS inoculation Babesiosis or their equivalent (1) Shiga toxin-related disease Botulism Influenza-associated death (gastroenteritis) Brucellosis Influenza-associated hospitalization (7) Shigellosis Campylobacteriosis Lead toxicity (blood level > 15 µg/dL) Silicosis Carbon monoxide poisoning (3) Legionellosis Smallpox Chancroid Listeriosis Staphylococcal enterotoxin B pulmonary Chickenpox Lyme disease poisoning Chickenpox-related death Malaria Staphylococcus aureus disease, Chlamydia (C. trachomatis) (all sites) Measles reduced or resistant susceptibility to Cholera Melioidosis vancomycin (1) Cryptosporidiosis Meningococcal disease Staphylococcus aureus methicillin- Cyclosporiasis Mercury poisoning resistant disease, invasive, community Diphtheria Mumps acquired (5,10) Ehrlichiosis/Anaplasmosis Neonatal herpes (< 60 days of age) Staphylococcus epidermidis disease, Escherichia coli O157:H7 gastroenteritis Neonatal bacterial sepsis (8) reduced or resistant susceptibility Gonorrhea Occupational asthma to vancomycin (1) Group A Streptococcal disease, invasive (4) Outbreaks: Syphilis Group B Streptococcal disease, invasive (4) ▪ Foodborne (involving > 2 persons) Tetanus Haemophilus influenzae disease, invasive ▪ Institutional Trichinosis all serotypes (4) ▪ Unusual disease or illness (9) Tuberculosis Hansen’s disease (Leprosy) Pertussis Tularemia Healthcare-associated Infections (5)* Plague Typhoid fever Hemolytic-uremic syndrome (6)* Pneumococcal disease, invasive (5) Vaccinia disease Hepatitis A Poliomyelitis Venezuelan equine encephalitis Hepatitis B Q fever Vibrio infection (parahaemolyticus, ▪ acute infection (2) Rabies (human and animal) vulnificus, other) ▪ HBsAg positive pregnant women Rheumatic fever Viral hemorrhagic fever Hepatitis C - acute infection (2) Ricin poisoning Yellow fever HIV-1 infection in (1) Rocky Mountain spotted fever ▪ persons with active tuberculosis disease Rotavirus ▪ persons with a latent tuberculous Rubella (including congenital) infection (history or tuberculin skin test Salmonellosis FOOTNOTES: 1. Report only to State. from LTACHs and IRFs, and NHSN dialysis event measures from 2. CDC case definition. outpatient hemodialysis centers.* 3. Includes persons being treated in hyperbaric chambers for suspect CO 6. On request from the DPH and if adequate serum is available, send serum poisoning. from patients with HUS to the DPH Laboratory for antibody testing.* 4. Invasive disease: confirmed by isolation from sterile fluid (blood, 7. Reporting requirements are satisfied by submitting the Hospitalized and Fatal CSF,pericardial, pleural, peritoneal, joint, or vitreous) bone, internal body sites, Cases of Influenza—Case Report Form to the DPH (or in Middlesex and New or other normally sterile site including muscle. Haven counties to Yale Emerging Infections Program at 203-764-4357); in a 5. The Reportable Conditions list is expanded to follow the CMS annual manner specified by the DPH. payment update pay-for-reporting or pay-for-performance reporting 8. Clinical sepsis and blood or CSF isolate obtained from an infant < 72 hours requirements for 2013. Therefore, reporting in Connecticut, which uses of age. the CDC's National Healthcare Safety Network (NSHN) surveillance 9. Individual cases of “significant unusual illness” are also reportable. definitions, protocols, and software, is expanded to include MRSA and C. 10. Community-acquired: infection present on admission to hospital, and person has difficile LabID event data from acute care hospitals, CLABSIs and CAUTIs no previous hospitalizations or regular contact with the health-care setting. How to report: The PD-23 is the general disease reporting form and should be used if other specialized forms are not available. Specialized reporting forms from the following programs